B6Brd;B6N-Tyrc-Brd Akap9tm1a(KOMP)Wtsi/WtsiOrl

Status

Available to order

EMMA IDEM:15217
International strain nameB6Brd;B6N-Tyrc-Brd Akap9tm1a(KOMP)Wtsi/WtsiOrl
Alternative nameEPD0033_5_D02
Strain typeTargeted Mutant Strains
Allele/Transgene symbolAkap9tm1a(KOMP)Wtsi
Gene/Transgene symbolAkap9
DisclaimerPlease note that for EUCOMM and KOMP-CSD mice supplied to the scientific community by INFRAFRONTIER/EMMA:
  1. We can not guarantee a null mutation for Knock-out first alleles (tm1a alleles, see http://www.mousephenotype.org/about-ikmc/targeting-strategies) as the critical exon has not been deleted.
  2. That the structure of the targeted mutation in the ES cells obtained from EUCOMM/KOMP to generate EUCOMM/KOMP mice is not verified by INFRAFRONTIER/EMMA. It is recommended that the recipient confirms the mutation structure.
  3. No check for determining the copy number of the targeting construct in ES cells obtained from EUCOMM/KOMP is done by INFRAFRONTIER/EMMA.
  4. The level of quality control before mice are released is to confirm the individual mouse genotype by short range PCR.

Information from provider

Provider Wellcome Trust Sanger Institute
Provider affiliationWellcome Trust Sanger Institute
Genetic informationThis mouse line originates from KOMP ES clone EPD0033_5_D02. For further details on the construction of this clone see the page at the IMPC portal.
Phenotypic informationPotential phenotyping data in the IMPC portal
References
  • Genome-wide generation and systematic phenotyping of knockout mice reveals new roles for many genes.;White Jacqueline K, Gerdin Anna-Karin, Karp Natasha A, Ryder Ed, Buljan Marija, Bussell James N, Salisbury Jennifer, Clare Simon, Ingham Neil J, Podrini Christine, Houghton Richard, Estabel Jeanne, Bottomley Joanna R, Melvin David G, Sunter David, Adams Niels C, null null, Tannahill David, Logan Darren W, Macarthur Daniel G, Flint Jonathan, Mahajan Vinit B, Tsang Stephen H, Smyth Ian, Watt Fiona M, Skarnes William C, Dougan Gordon, Adams David J, Ramirez-Solis Ramiro, Bradley Allan, Steel Karen P, ;2013;Cell;154;452-64; 23870131

Information from EMMA

Archiving centreInstitut de Transgenose, INTRAGENE, Orléans, France

Disease and phenotype information

Orphanet associated rare diseases, based on orthologous gene matching

IMPC phenotypes (allele matching)
  • increased bone mineral density / IMPC
  • decreased circulating LDL cholesterol level / IMPC
  • decreased circulating HDL cholesterol level / IMPC
  • abnormal head morphology / IMPC
  • decreased body weight / IMPC
  • increased circulating alkaline phosphatase level / IMPC
  • decreased circulating cholesterol level / IMPC
  • decreased circulating serum albumin level / IMPC
  • increased circulating amylase level / IMPC
  • decreased total body fat amount / IMPC
  • preweaning lethality, incomplete penetrance / IMPC
IMPC phenotypes (gene matching)
  • decreased circulating cholesterol level / IMPC
  • decreased circulating HDL cholesterol level / IMPC
  • decreased circulating LDL cholesterol level / IMPC
  • decreased body weight / IMPC
  • increased circulating alkaline phosphatase level / IMPC
  • decreased circulating serum albumin level / IMPC
  • decreased total body fat amount / IMPC
  • preweaning lethality, incomplete penetrance / IMPC
  • increased circulating amylase level / IMPC
  • increased bone mineral density / IMPC
  • abnormal head morphology / IMPC
MGI phenotypes (allele matching)
  • decreased circulating LDL cholesterol level / MGI
  • decreased circulating HDL cholesterol level / MGI
  • decreased body weight / MGI
  • abnormal tooth morphology / MGI
  • increased circulating alkaline phosphatase level / MGI
  • decreased lean body mass / MGI
  • abnormal pelvic girdle bone morphology / MGI
  • increased energy expenditure / MGI
  • increased T cell number / MGI
  • decreased B cell number / MGI
  • decreased circulating cholesterol level / MGI
  • increased oxygen consumption / MGI
  • decreased circulating serum albumin level / MGI
  • decreased percent body fat/body weight / MGI
  • decreased circulating glucose level / MGI
  • decreased circulating total protein level / MGI
  • increased CD4-positive, alpha beta T cell number / MGI
  • increased CD8-positive, alpha-beta T cell number / MGI
  • decreased mature B cell number / MGI
  • increased carbon dioxide production / MGI
  • decreased total body fat amount / MGI
  • lethality, incomplete penetrance / MGI
  • decreased circulating calcium level / MGI
  • abnormal head morphology / MGI
  • increased circulating fructosamine level / MGI
  • decreased circulating fructosamine level / MGI
  • decreased lumbar vertebrae number / MGI
MGI phenotypes (gene matching)
  • decreased circulating LDL cholesterol level / MGI
  • decreased circulating HDL cholesterol level / MGI
  • decreased circulating calcium level / MGI
  • abnormal head morphology / MGI
  • abnormal testis morphology / MGI
  • arrest of spermatogenesis / MGI
  • abnormal spermatogenesis / MGI
  • decreased body weight / MGI
  • male infertility / MGI
  • abnormal tooth morphology / MGI
  • abnormal seminiferous tubule morphology / MGI
  • globozoospermia / MGI
  • oligozoospermia / MGI
  • increased circulating alkaline phosphatase level / MGI
  • decreased lean body mass / MGI
  • abnormal Sertoli cell development / MGI
  • abnormal pelvic girdle bone morphology / MGI
  • decreased lumbar vertebrae number / MGI
  • decreased testis weight / MGI
  • increased energy expenditure / MGI
  • decreased seminal vesicle weight / MGI
  • increased T cell number / MGI
  • decreased B cell number / MGI
  • azoospermia / MGI
  • decreased circulating cholesterol level / MGI
  • increased oxygen consumption / MGI
  • decreased circulating serum albumin level / MGI
  • decreased percent body fat/body weight / MGI
  • decreased circulating glucose level / MGI
  • decreased circulating total protein level / MGI
  • abnormal spermatocyte morphology / MGI
  • increased CD4-positive, alpha beta T cell number / MGI
  • increased CD8-positive, alpha-beta T cell number / MGI
  • decreased mature B cell number / MGI
  • arrest of male meiosis / MGI
  • increased carbon dioxide production / MGI
  • decreased total body fat amount / MGI
  • increased circulating fructosamine level / MGI
  • decreased circulating fructosamine level / MGI
  • lethality, incomplete penetrance / MGI

Literature references

  • Genome-wide generation and systematic phenotyping of knockout mice reveals new roles for many genes.;White Jacqueline K, Gerdin Anna-Karin, Karp Natasha A, Ryder Ed, Buljan Marija, Bussell James N, Salisbury Jennifer, Clare Simon, Ingham Neil J, Podrini Christine, Houghton Richard, Estabel Jeanne, Bottomley Joanna R, Melvin David G, Sunter David, Adams Niels C, null null, Tannahill David, Logan Darren W, Macarthur Daniel G, Flint Jonathan, Mahajan Vinit B, Tsang Stephen H, Smyth Ian, Watt Fiona M, Skarnes William C, Dougan Gordon, Adams David J, Ramirez-Solis Ramiro, Bradley Allan, Steel Karen P, ;2013;Cell;154;452-64; 23870131

Information on how we integrate external resources can be found here

Order

Availabilities

Requesting frozen sperm or embryos is generally advisable wherever possible, in order to minimise the shipment of live mice.

  • Frozen sperm. Delivered in 4 weeks (after paperwork in place). €1740*
  • Rederivation of mice from frozen stock, delivery time available upon request . €3880*

Due to the dynamic nature of our processes strain availability may change at short notice. The local repository manager will advise you in these circumstances.

* In addition users have to cover all the shipping costs (including the cost for returning dry-shippers, where applicable).

More details on pricing and delivery times

Practical information

Example health report
(Current health report will be provided later)

Material Transfer Agreement (MTA)
Distribution of this strain is subject to a provider MTA. Both signing of the MTA and submission of the online EMMA Mutant Request Form are required before material can be shipped.

EMMA conditions
Legally binding conditions for the transfer

Other EMMA strains

Not found what you were looking for? Search here for other strains available from EMMA.


Search
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).